“Media studies explain it for a loophole,” suggests Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s quite intentional policy.” Brunner has expressed stress about how some coverage in the rise of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medications or analysis peptides with credentialed operations https://andreiv297uyq6.wikikarts.com/user